缺氧及多发性骨髓瘤骨髓微环境中CD8+ T细胞的mTOR活性与代谢重编程受损
本研究评估缺氧条件下CD8+ T细胞对刺激的应答,发现缺氧深度抑制活化、增殖和干扰素-γ分泌,但不影响细胞毒性和肿瘤坏死因子-α表达,同时mTOR活性及c-Myc表达下降、糖酵解和线粒体谷氨酰胺氧化减弱。机制上与缺氧诱导的BNIP3升高及Rheb减少相关。BCMA×CD3双特异性抗体在缺氧下激发CD8+ T细胞活化的能力受损。多发性骨髓瘤患者骨髓CD8+ T细胞较外周血增殖、c-Myc和Rheb表达降低而BNIP3升高,提示骨髓缺氧可能影响T细胞导向疗法的疗效。
要点
- 缺氧抑制CD8+ T细胞活化、增殖和IFN-γ分泌,但不影响细胞毒性和TNF-α表达。
- 缺氧下mTOR活性及c-Myc表达下降,伴糖酵解和线粒体谷氨酰胺氧化减弱。
- 多发性骨髓瘤患者骨髓CD8+ T细胞较外周血增殖、c-Myc和Rheb降低而BNIP3升高。
核心结论
- 研究结果表明骨髓缺氧可能影响多发性骨髓瘤T细胞导向疗法的疗效。
研究设计与样本
- 本研究在缺氧条件下评估CD8+ T细胞对刺激的应答,并检测多发性骨髓瘤患者骨髓与外周血CD8+ T细胞。
主要发现
- 缺氧下CD8+ T细胞活化、增殖和IFN-γ分泌被深度抑制,而细胞毒性和TNF-α表达未受影响。
- 缺氧下mTOR活性及c-Myc表达下降,活化诱导的糖酵解和线粒体谷氨酰胺氧化减少。
- 缺氧下BNIP3表达升高,其相互作用伙伴Rheb丰度相应降低。
- BCMA×CD3双特异性抗体在缺氧下激发CD8+ T细胞活化、IFN-γ表达、增殖及记忆分化的能力受损,但初始靶细胞杀伤未受影响。
- 多发性骨髓瘤患者骨髓CD8+ T细胞较外周血细胞增殖、c-Myc和Rheb表达降低,BNIP3升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Novel therapies for multiple myeloma (MM) aim to engage antitumor functions of T cells. However, evidence indicates these functions are limited within the bone marrow (BM) environment. This is relatively hypoxic in health, and studies indicate widespread hypoxia in MM. In this study, CD8+ T-cell responses to stimulation were assessed under hypoxia, which identified that activation, proliferation, and interferon-gamma (IFN-γ) secretion were profoundly suppressed, while cytotoxicity and tumor necrosis factor-α (TNF-α) expression were unaffected. These changes occurred alongside decreased mechanistic target of rapamycin (mTOR) activity and expression of c-Myc, which drives T-cell metabolic reprogramming upon stimulation. Consistently, hypoxic CD8+ T cells demonstrated decreased activation-induced glycolysis and mitochondrial glutamine oxidation. Mechanistically, this was linked to elevated BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) expression under hypoxia, and reciprocally decreased abundance of its interaction partner, Ras homolog enriched in brain (Rheb), an important mTOR activator. Assessment of BCMA×CD3 bispecific antibody activity confirmed impaired capacity to elicit CD8+ T-cell activation, IFN-γ expression, proliferation, and altered memory differentiation under hypoxia, although initial target cell killing was unaffected. Finally, assessment of BM CD8+ T cells from patients with MM identified decreased proliferation, c-Myc, and Rheb expression compared with peripheral blood cells, alongside elevated BNIP3, confirming mechanistic features of hypoxic exposure in this environment. Taken together, the findings indicate potential for BM hypoxia to influence efficacy of T cell-directed therapies for MM.
引用
- Fulton-Ward T, Gudgeon N, Thirlwell I, et al. mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow. Blood Adv. 2025. PMID: 40938732. doi:10.1182/bloodadvances.2025016439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。